Nephroplus Promoters Sell 2.44% Stake Worth Rs 104.18 Crore Ahead of IPO

• Promoters sold a 2.44% stake in Nephroplus, worth over Rs 100 crore, ahead of its IPO.
• Nephroplus, Asia's largest dialysis services provider, aims to raise Rs 871 crore through its IPO.
• The IPO will open from December 10-12, with a price band of Rs 438-460 per share.
• Key buyers of the pre-IPO stake included TIMF Holdings, Malabar India Fund, and Axis Max Life Insurance.
• The company plans to use fresh issue proceeds to open 167 new dialysis clinics and repay borrowings.

Why It Matters: Pre-IPO promoter stake sale impacts company ownership and investor confidence.